Strategikon Pharma Wins Acquisition International 2023 Award for Best End-to-End Clinical Business Operations Solution
Unique Clinical Maestro Platform Efficiently Budgets, Sources, and Manages Complex Clinical Studies San Francisco, CA – April 25, 2023 – Strategikon Pharma, a leading provider of innovative clinical business solutions, [...]
Revolutionary New Features and Functionality for Biopharmaceutical Outsourcing
Revolutionary New Features and Functionality for Biopharmaceutical Outsourcing Strategikon introduces Clinical Maestro 4.0 SAN FRANCISCO, April 4, 2023 -- Strategikon announced today the release of Clinical Maestro 4.0, adding [...]
Strategikon and 4C Join Forces to Streamline Biopharmaceutical Clinical Operations
Strategikon and 4C Join Forces to Streamline Biopharmaceutical Clinical Operations Strategic Partnership Will Accelerate Clinical Outsourcing for Biopharma of All Sizes SAN FRANCISCO, February 7, 2023 -- Strategikon Pharma and [...]
Strategikon Pharma Announces the Release of Clinical Maestro® SOURCE 3.0
Strategikon Pharma Announces the Release of Clinical Maestro® SOURCE 3.0 Change Orders, Adaptive and Complex Design Studies, Enhanced RFP Experience and More SAN FRANCISCO, May 11, 2022 -- Strategikon Pharma [...]
Strategikon Pharma Completes Sponsor Suite of SaaS-based Tools with VISION Application
First-to-Market Vendor Management Application for Pharma R&D Strategikon Pharma Completes Sponsor Suite of SaaS-based Tools with VISION Application SAN FRANCISCO, February 7, 2022 -- Strategikon Pharma announced today they are [...]
Brian Kelly joins Strategikon Pharma as Senior Vice President, Business Development
This Strategikon interview illuminates the challenges and rewards of becoming the newest addition to the Strategikon Pharma management team. Through this conversation, Brian Kelly describes why he chose to join [...]